Literature DB >> 6465417

The spectrum of carcinoma arising in Barrett's esophagus. A clinicopathologic study of 26 patients.

R R Smith, S R Hamilton, J K Boitnott, E L Rogers.   

Abstract

The clinical and pathologic features of carcinoma arising in Barrett's esophagus were studied in resection specimens from 26 patients. White males predominated (73%). A history of symptomatic gastroesophageal reflux was frequently absent, being elicited in only eight of 14 patients (57%) with a carefully obtained history at the time of presentation with carcinoma. Survival was relatively short with a median survival of 23 +/- 5 months, and only three patients had a disease-free survival longer than 2 years. A pathologic spectrum of carcinoma was found: differentiation ranged from well to poorly differentiated in the 20 patients with a single adenocarcinoma; two separate carcinomas were found in four patients; and a spectrum of differentiation in a single tumor was found in the other two cases, one an adenocarcinoid tumor and the other an adenosquamous carcinoma. The tumors were generally far advanced, with extension through the esophageal wall in 23 of 26 cases (88%) and metastases to lymph nodes in 17 of 24 cases (71%). Epithelial dysplasia, including carcinoma in situ in some cases, was found in Barrett's mucosa adjacent to the tumor in all 26 patients. Our findings suggest that a surveillance program for dysplasia in patients known to have Barrett's esophagus is warranted in an attempt to improve the outcome. However, the impact of surveillance on the incidence of Barrett's carcinoma may be lessened by its frequent occurrence in patients with asymptomatic gastroesophageal reflux.

Entities:  

Mesh:

Year:  1984        PMID: 6465417     DOI: 10.1097/00000478-198408000-00001

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  31 in total

1.  Early and late results of the acid suppression and duodenal diversion operation in patients with barrett's esophagus: analysis of 210 cases.

Authors:  Attila Csendes; Patricio Burdiles; Italo Braghetto; Owen Korn; Juan Carlos Díaz; Jorge Rojas
Journal:  World J Surg       Date:  2002-03-01       Impact factor: 3.352

Review 2.  [Barrett's esophagus. An update].

Authors:  G B Baretton; D E Aust
Journal:  Pathologe       Date:  2012-02       Impact factor: 1.011

3.  Barrett's esophagus in children and young adults. Frequent association with mental retardation.

Authors:  J D Snyder; H Goldman
Journal:  Dig Dis Sci       Date:  1990-10       Impact factor: 3.199

Review 4.  Barrett esophagus: histology and pathology for the clinician.

Authors:  Robert D Odze
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-07-07       Impact factor: 46.802

5.  Comparison of reflux esophagitis and its complications between African Americans and non-Hispanic whites.

Authors:  Kenneth J Vega; Sian Chisholm; M Mazen Jamal
Journal:  World J Gastroenterol       Date:  2009-06-21       Impact factor: 5.742

6.  Carcinogenesis of Barrett's esophagus: a review of the clinical literature.

Authors:  Jiro Watari; Tadayuki Oshima; Hirokazu Fukui; Toshihiko Tomita; Hiroto Miwa
Journal:  Clin J Gastroenterol       Date:  2013-08-14

Review 7.  Carcinoma of the gastroesophageal junction in Chinese patients.

Authors:  Qin Huang
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

8.  Effect of duodenal diversion on low-grade dysplasia in patients with Barrett's esophagus: analysis of 37 patients.

Authors:  Attila Csendes; Gladys Smok; Patricio Burdiles; Italo Braghetto; Cesar Castro; Owen Korn
Journal:  J Gastrointest Surg       Date:  2002 Jul-Aug       Impact factor: 3.452

9.  Carcinosarcoma in Barrett's oesophagus: a case report with immunohistological examination.

Authors:  O Dworak; H P Koerfgen
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

10.  Time trend and age-period-cohort effects on incidence of esophageal cancer in Connecticut, 1935-89.

Authors:  T Zheng; S T Mayne; T R Holford; P Boyle; W Liu; Y Chen; M Mador; J Flannery
Journal:  Cancer Causes Control       Date:  1992-09       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.